Primary Radiotherapy of Stage IIA/B-IIIB Cervical Carcinoma: A Comparison of Continuous Versus Sequential Regimens

Strahlentherapie und Onkologie

Volumn 180, Issue 4, 2004, Pages 209-215

  Mayer, Árpád ^a   Nemeskéri, Csaba ^a   Petneházi, Csaba ^a   Borgulya, Gábor ^b   Varga, Szilvia ^a   Naszály, Attila ^a  

^a UZSOKI HOSPITAL   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cervical cancer; Continuous regimen; High dose rate brachytherapy; Late side effects; Locoregional control; Overall treatment time; Sequential regimen

Indexed keywords

ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; RECTUM DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; CONFIDENCE INTERVALS; CYSTOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARNOFSKY PERFORMANCE STATUS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOGRAPHY, ABDOMINAL; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 1842665077     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1122-8     Document Type: Article

References (24)

1. Altman DG, De Stavola BL, Love SB, et al. Review of survival analyses published in cancer journals. Br J Cancer 1995;72:511-8.
2. Busch M 2nd, Dühmke E, Kuhn W, et al. Definitive radiation therapy in the treatment of carcinoma of the uterine cervix. Treatment results and prognostic factors. Strahlenther Onkol 1991;167:628-37.
3. Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993;27:1051-6.
4. Haensgen G, Kuhnt T, Pigorsch S, et al. Adjuvant simultaneous radiochemotherapy following radical hysterectomy for patients with cervical cancers in high-risk situation - results of a pilot study. Strahlenther Onkol 2002;178:71-7.
5. Han I, Malviya V, Chuba P, et al. Multifractioned high-dose-rate brachytherapy with concomitant daily teletherapy for cervical cancer. Gynecol Oncol 1996;63:71-7.
6. Harima Y, Nagata K, Harima K, et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2001;17:97-105.
7. Hehr T. Role of primary radiotherapy plus deep regional hyperthermia in advanced stage FIGO IIb-IV cervical carcinoma. Strahlenther Onkol 2000;176:485-6.
8. Itami J, Hara R, Kozuka T, et al. Transperineal high-dose-rate radiation therapy in the management of gynecologic malignancies. Strahlenther Onkol 2003;179:737-41.
9. Kapp KS, Stuecklschweiger GF, Kapp DS, et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and Ir-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1998;42:531-40.
10. Kataoka M, Kawamura M, Nishiyama Y, et al. Results of the combination of external-beam and high-dose-rate intracavitary irradiation for patients with cervical carcinoma. Gynecol Oncol 1992;44:48-52.
11. Kobierska A, Gerbaulet AP. Exclusive radiotherapy in the management of carcinoma of the uterine cervix. Hung J Gynecol Oncol 1996;1:175-9.
12. Le Pechoux C, Akine Y, Sumi M, et al. High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens. Int J Radiat Oncol Biol Phys 1995;31:735-41.
13. Marcial VA, Marcial LV. Radiation therapy of cervical cancer. Cancer Suppl 1993;71:1438-45.
14. Nag S, Erickson B, Thomadsen B. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;48:201-11.
15. Orecchia R, Gatti GM, Leonardi MC, et al. Perspectives of radiation therapy in the treatment of advanced stages (III and IV) of cervix carcinoma. Hung J Gynecol Oncol 1996;1:193-6.
16. Pedersen D, Sogaard H, Overgaard J, et al. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncol 1995;34:787-95.
17. Perez CA, Fox S, Lockett MA, et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys 1991;21:885-98.
18. Perez CA, Grigsby PW, Castro-Vita H, et al. Carcinoma of the uterine cervix. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;32:1275-88.
19. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999;43:359-66.
20. Petereit DG, Sakaria JN, Chapell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1301-7.
21. Rose PG. Combined-modality treatment of locally advanced cervical cancer. J Clin Oncol 2003;21(10 Suppl):211-7.
22. Strauss HG, Kuhnt T, Laban C, et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy - results of a phase-II study. Strahlenther Onkol 2002;178:378-85.
23. Van der Zee J, González Z, Van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomized, multicentre trial. Lancet 2000;355:1119-25.
24. Vaupel P, Thews O, Mayer A, et al. Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level? Strahlenther Onkol 2002;178:727-31.